{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:41:34Z","timestamp":1790905294934,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CIHR MOP","award":["MOP130333"],"award-info":[{"award-number":["MOP130333"]}]},{"name":"Baker Institute of Cornell University"},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["15-15-00053"],"award-info":[{"award-number":["15-15-00053"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.antiviral.2017.11.018","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T17:50:06Z","timestamp":1511805006000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Antivirals acting on viral envelopes via biophysical mechanisms of action"],"prefix":"10.1016","volume":"149","author":[{"given":"Sietske","family":"Speerstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey A.","family":"Chistov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleb V.","family":"Proskurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Aralov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor A.","family":"Ulashchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp P.","family":"Streshnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim V.","family":"Shmanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Korshun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Schang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.11.018_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1086\/653534","article-title":"Palivizumab-resistant human respiratory syncytial virus infection in infancy","volume":"51","author":"Adams","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.11.018_bib2","doi-asserted-by":"crossref","first-page":"E1609","DOI":"10.1073\/pnas.1119442109","article-title":"Energetics of stalk intermediates in membrane fusion are controlled by lipid composition","volume":"109","author":"Aeffner","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2017.11.018_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1023\/A:1023936516589","article-title":"Antiviral activity of some 5-arylethynyl 2\u2019-deoxyuridine derivatives","volume":"29","author":"Andronova","year":"2003","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.antiviral.2017.11.018_bib4","first-page":"1137","article-title":"Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells","author":"Anggakusuma","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2017.11.018_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2017.06.014","article-title":"Perylenyltriazoles inhibit reproduction of enveloped viruses","volume":"138","author":"Aralov","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.11.018_bib6","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbamem.2014.04.015","article-title":"Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity","volume":"1838","author":"Badani","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2017.11.018_bib7","first-page":"4","article-title":"The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts","author":"Berridge","year":"1996","journal-title":"Biochemica"},{"key":"10.1016\/j.antiviral.2017.11.018_bib8","doi-asserted-by":"crossref","first-page":"12378","DOI":"10.1021\/jp010118h","article-title":"Effect of unsaturated lipid chains on dimensions, molecular order and hydration of membranes","volume":"105","author":"Binder","year":"2001","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.antiviral.2017.11.018_bib9","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1073\/pnas.0801388105","article-title":"Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus","volume":"105","author":"Bobardt","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.11.018_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbpa.2015.10.003","article-title":"Three steps forward, two steps back: mechanistic insights into the assembly and disassembly of the SNARE complex","volume":"29","author":"Bombardier","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib11","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1529\/biophysj.108.133173","article-title":"The hydrophobic insertion mechanism of membrane curvature generation by proteins","volume":"95","author":"Campelo","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2017.11.018_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.05722-11","article-title":"PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus","volume":"56","author":"Chamoun","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.11.018_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bpj.2015.05.021","article-title":"Synaptobrevin transmembrane domain influences exocytosis by perturbing vesicle membrane curvature","volume":"109","author":"Chang","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2017.11.018_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/35052017","article-title":"SNARE-mediated membrane fusion","volume":"2","author":"Chen","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib15","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.0712380105","article-title":"A virocidal amphipathic \u03b1-helical peptide that inhibits hepatitis C virus infection in vitro","volume":"105","author":"Cheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.11.018_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2005.10.015","article-title":"Membrane hemifusion: crossing a chasm in two leaps","volume":"123","author":"Chernomordik","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2017.11.018_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.biochem.72.121801.161504","article-title":"Protein-lipid interplay in fusion and fission of biological membranes","volume":"72","author":"Chernomordik","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2017.11.018_bib18","first-page":"1","article-title":"Lipids in biological membrane fusion","volume":"14","author":"Chernomordik","year":"1995","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib19","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/JVI.69.5.3049-3058.1995","article-title":"Control of baculovirus gp64-induced syncytium formation by membrane lipid composition","volume":"69","author":"Chernomordik","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0005-2736(85)90257-3","article-title":"The shape of lipid molecules and monolayer membrane fusion","volume":"812","author":"Chernomordik","year":"1985","journal-title":"BBA Biomembr."},{"key":"10.1016\/j.antiviral.2017.11.018_bib21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1083\/jcb.140.6.1369","article-title":"The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation","volume":"140","author":"Chernomordik","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1083\/jcb.136.1.81","article-title":"An early stage of membrane fusion mediated by the low pH conformation of influenza haemagglutinin depends upon membrane lipids","volume":"136","author":"Chernomordik","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib23","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1016\/j.tetlet.2016.09.050","article-title":"Fluorescent nucleosides with an elongated rigid linker: attaching perylene to a nucleobase via a one-pot desilylation\/Sonogashira reaction","volume":"57","author":"Chistov","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.antiviral.2017.11.018_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/00304948.2017.1343040","article-title":"Improved large-scale synthesis of 5-(perylen-3-ylethynyl)-arabino-uridine (aUY11), the broad-spectrum antiviral","volume":"49","author":"Chistov","year":"2017","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.antiviral.2017.11.018_bib25","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1038\/nmicrobiol.2016.50","article-title":"The hemifusion structure induced by influenza virus haemagglutinin is determined by physical properties of the target membranes","author":"Chlanda","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib26","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.11.018_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2017.11.018_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00232-004-0669-8","article-title":"The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement","volume":"199","author":"Cohen","year":"2004","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-016-9724-7","article-title":"Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals","volume":"10","author":"Colpitts","year":"2016","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.antiviral.2017.11.018_bib30","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/JVI.00896-14","article-title":"A small molecule inhibits virion attachment to heparan sulfate- or sialic Acid-containing glycans","volume":"88","author":"Colpitts","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib31","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/JVI.02882-12","article-title":"5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses","volume":"87","author":"Colpitts","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib32","first-page":"4721","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.11.018_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0005-2736(03)00169-X","article-title":"Fusion peptides and the mechanism of viral fusion","volume":"1614","author":"Epand","year":"2003","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2017.11.018_bib35","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm1319","article-title":"Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1","volume":"11","author":"F\u00e4tkenheuer","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2017.11.018_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1083\/jcb.200409068","article-title":"Interdependent assembly of specific regulatory lipids and membrane fusion proteins into the vertex ring domain of docked vacuoles","volume":"167","author":"Fratti","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1083\/jcb.150.3.601","article-title":"Rabies virus-induced membrane fusion pathway","volume":"150","author":"Gaudin","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkh330","article-title":"Resistance to enfuvirtide, the first HIV fusion inhibitor","volume":"54","author":"Greenberg","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2017.11.018_bib39","first-page":"29279","article-title":"Inhibition of membrane fusion by lysophosphatidylcholine","volume":"270","author":"Gunther Ausborn","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2017.11.018_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20051069","article-title":"The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope","volume":"392","author":"Harada","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2017.11.018_bib41","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib42","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.bbamem.2012.05.020","article-title":"Biophysics of lipid bilayers containing oxidatively modified phospholipids: insights from fluorescence and EPR experiments and from MD simulations","volume":"1818","author":"Jurkiewicz","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2017.11.018_bib43","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/3293","article-title":"Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry","volume":"4","author":"Kilby","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2017.11.018_bib44","doi-asserted-by":"crossref","first-page":"44676","DOI":"10.1038\/srep44676","article-title":"A novel inhibitor IDPP interferes with entry and egress of HCV by targeting glycoprotein E1 in a genotype-specific manner","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2017.11.018_bib45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1073\/pnas.90.1.158","article-title":"Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation","volume":"90","author":"Lenard","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.11.018_bib46","series-title":"Reconstitution of Rab- and SNARE-dependent Membrane Fusion by Synthetic Endosomes","first-page":"459","author":"Lommer","year":"2009"},{"key":"10.1016\/j.antiviral.2017.11.018_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1091\/mbc.11.4.1143","article-title":"The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores","volume":"11","author":"Markosyan","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.antiviral.2017.11.018_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrm2417","article-title":"Mechanisms of membrane fusion: disparate players and common principles","volume":"9","author":"Martens","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nature04396","article-title":"Membrane curvature and mechanisms of dynamic cell membrane remodelling","volume":"438","author":"McMahon","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.11.018_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2010.02.017","article-title":"Membrane curvature in synaptic vesicle fusion and beyond","volume":"140","author":"McMahon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2017.11.018_bib51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbamem.2008.10.002","article-title":"Spin labeling EPR studies of the properties of oxidized phospholipid-containing lipid vesicles","volume":"1788","author":"Megli","year":"2009","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2017.11.018_bib52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1083\/jcb.131.3.679","article-title":"Gpi-Anchored influenza hemagglutinin induces hemifusion to both red-blood-cell and planar bilayer-membranes","volume":"131","author":"Melikyan","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2017.03.007","article-title":"Antiviral lectins: selective inhibitors of viral entry","volume":"142","author":"Mitchell","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.018_bib54","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0006-3495(03)74601-3","article-title":"Kinetically differentiating influenza hemagglutinin fusion and hemifusion machines","volume":"85","author":"Mittal","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2017.11.018_bib55","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbalip.2015.12.020","article-title":"On the molecular mechanism of flippase- and scramblase-mediated phospholipid transport","volume":"1861","author":"Montigny","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.antiviral.2017.11.018_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature19326","article-title":"An endosomal tether undergoes an entropic collapse to bring vesicles together","volume":"537","author":"Murray","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.11.018_bib57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1039\/C5MD00538H","article-title":"Rigid amphipathic nucleosides suppress reproduction of the tick-borne encephalitis virus","volume":"7","author":"Orlov","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.antiviral.2017.11.018_bib58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/C5SC02311D","article-title":"Effect of lipid peroxidation on membrane permeability of cancer and normal cells subjected to oxidative stress","volume":"7","author":"Van der Paal","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.antiviral.2017.11.018_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01914-16","article-title":"Clinically approved ion channel inhibitors close gates for hepatitis C virus \u2013and open doors for drug repurposing in viral infectious diseases","volume":"91","author":"Pietschmann","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1562\/0031-8655(2000)0710188SFEOEV2.0.CO2","article-title":"Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin","volume":"71","author":"Prince","year":"2000","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib61","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.01863-12","article-title":"HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120","volume":"87","author":"Ratcliff","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib62","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dkv026","article-title":"Virological failure of patients on maraviroc-based antiretroviral therapy","volume":"70","author":"Raymond","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2017.11.018_bib63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1067\/mjd.2001.116215","article-title":"Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial","volume":"45","author":"Sacks","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"issue":"13","key":"10.1016\/j.antiviral.2017.11.018_bib64","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00018-017-2478-0","article-title":"Deciphering the BAR code of membrane modulators","volume":"74","author":"Salzer","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2017.11.018_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/0968768031000104953","article-title":"Regulated exocytosis and SNARE function ( Review )","volume":"20","author":"S\u00f6llner","year":"2003","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1067\/mjd.2002.122743","article-title":"N-docosanol (Abreva) for herpes labialis: problems and questions","volume":"47","author":"Spruance","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib67","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ncb2832","article-title":"A cost-benefit analysis of the physical mechanisms of membrane curvature","volume":"15","author":"Stachowiak","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib68","doi-asserted-by":"crossref","first-page":"17339","DOI":"10.1073\/pnas.1010026107","article-title":"Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses","volume":"107","author":"St Vincent","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.11.018_bib69","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0006-3495(02)75223-5","article-title":"The effects of acyl chain length and saturation of diacylglycerols and phosphatidylcholines on membrane monolayer curvature","volume":"83","author":"Szule","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2017.11.018_bib70","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/JVI.02907-13","article-title":"The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses","volume":"88","author":"Vigant","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib71","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib72","doi-asserted-by":"crossref","first-page":"25764","DOI":"10.1016\/S0021-9258(19)74455-X","article-title":"Lysophosphatidylcholine reversibly arrests exocytosis and viral fusion at a stage between triggering and membrane merger","volume":"268","author":"Vogel","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.11.018_bib73","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/587660","article-title":"The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen","volume":"46","author":"Waters","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.11.018_bib74","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tra.12389","article-title":"Fusion of enveloped viruses in endosomes","volume":"17","author":"White","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.antiviral.2017.11.018_bib75","first-page":"707","volume":"vol. 28","author":"Wickner","year":"2017"},{"issue":"5","key":"10.1016\/j.antiviral.2017.11.018_bib76","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1083\/jcb.201609071","article-title":"The crossover conformational shift of the GTPase atlastin provides the energy driving ER fusion","volume":"216","author":"Winsor","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib77","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.11.018_bib78","first-page":"1","article-title":"Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C","author":"Xiao","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2017.11.018_bib79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nsmb921","article-title":"Hemifusion in SNARE-mediated membrane fusion","volume":"12","author":"Xu","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib80","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1242\/jcs.119685","article-title":"Virus entry at a glance","volume":"126","author":"Yamauchi","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.antiviral.2017.11.018_bib81","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/bi00173a027","article-title":"Inhibition of membrane fusion by lysophosphatidylcholine","volume":"33","author":"Yeagle","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2017.11.018_bib82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1083\/jcb.200412059","article-title":"Class II fusion protein of alphaviruses drives membrane fusion through the pathway as class I proteins","volume":"169","author":"Zaitseva","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.11.018_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm1784","article-title":"How proteins produce cellular membrane curvature","volume":"7","author":"Zimmerberg","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217304928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217304928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T02:45:00Z","timestamp":1660013100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217304928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":83,"alternative-id":["S0166354217304928"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.11.018","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antivirals acting on viral envelopes via biophysical mechanisms of action","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}